Stockreport

Ocugen Announces Warrant Restructuring

Ocugen, Inc.  (OCGN) 
PDF MALVERN, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Ocugen, Inc., (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on discovering, developing and commerc [Read more]